Results 11 to 20 of about 18,622 (204)

Dipyridamole-induced adverse effects in myocardial perfusion scans: Dynamic evaluation

open access: yesInternational Journal of Cardiology: Heart & Vasculature, 2017
Aim and Background: Dipyridamole-induced stress myocardial perfusion scans (MPS) has been widely used for management of coronary artery disease. The adverse effects of dipyridamole and other stress agents have been evaluated.
Sin-Di Lee   +3 more
doaj   +2 more sources

Fluvastatin Plus Dipyridamole Suppresses Canine Hemangiosarcoma Growth in Patient-Derived Xenograft Models Through Lactate Dehydrogenase-Associated Cholesterol/Lipid Metabolism. [PDF]

open access: yesVet Comp Oncol
ABSTRACT Tumour cells commonly exhibit aerobic glycolysis and produce lactate despite oxygen availability. Lactate dehydrogenase (LDH) catalyses pyruvate‐lactate interconversion and regulates intracellular lactate levels. Endothelial cells also depend on glycolysis for ATP production, which prompted us to investigate LDH in canine hemangiosarcoma (HSA),
Suzuki T   +6 more
europepmc   +2 more sources

Dipyridamole induces the phosphorylation of CREB to promote cancer cell proliferation [PDF]

open access: yes, 2021
Dipyridamole, a traditional anti-platelet drug, has been reported to inhibit the proliferation of cancer cells. The present study aimed to investigate the possibility of dipyridamole as an adjuvant of chemotherapy by enhancing the cytotoxicity of an anti-
Abdelghany, Lina   +9 more
core   +2 more sources

QT DISPERSION AND DIPYRIDAMOLE-INDUCED MYOCARDIAL ISCHEMIA [PDF]

open access: yes, 2017
The relationship between QT interval dispersion and dipyridamole-induced, transient myocardial ischemia was assessed in 32 male patients with ischemic heart disease. A standardized, high dose dipyridamole-ECG stress test was used as dipyridamole infusion
Peychev, Y.   +3 more
core   +1 more source

Current and future use of dipyridamole in patients with COVID-19

open access: yesКачественная клиническая практика, 2020
Current use of dipyridamole in COVID-19 is mainly based on its antithrombotic activity, since there is no robust clinical effectiveness data. The decision to use dipyridamole in COVID-19 should be individualized, considering the experimental nature of ...
I. S. Burashnikova   +3 more
doaj   +1 more source

Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors

open access: yesFrontiers in Cardiovascular Medicine, 2022
IntroductionCardiovascular events are common in COVID-19. While the use of anticoagulation during hospitalization has been established in current guidelines, recommendations regarding antithrombotic therapy in the post-discharge period are conflicting ...
Lukas J. Motloch   +18 more
doaj   +1 more source

Cyclic AMP‐hydrolyzing phosphodiesterase inhibitors potentiate statin‐induced cancer cell death

open access: yesMolecular Oncology, 2020
Dipyridamole, an antiplatelet drug, has been shown to synergize with statins to induce cancer cell‐specific apoptosis. However, given the polypharmacology of dipyridamole, the mechanism by which it potentiates statin‐induced apoptosis remains unclear ...
Joseph Longo   +5 more
doaj   +1 more source

Effects of adenosine and dipyridamole on serum levels of some biochemical markers in rabbits: Running title: Biochemical effects of adenosine and dipyridamole

open access: yesTikrit Journal of Pure Science, 2022
Adenosine is a nucleoside which occurs naturally in a diverse forms in all cells of the body and in most biological fluids. Under basal conditions, the extracellular adenosine concentration is maintained within certain limits.
Taghreed Hazem Saber Alfakje   +2 more
doaj   +1 more source

Changes of electrocardiogram and hemodynamics in response to dipyridamole: In vivo comparative analyses using anesthetized beagle dogs and microminipigs

open access: yesJournal of Pharmacological Sciences, 2018
Microminipigs are expected as a novel animal model for cardiovascular pharmacological experiments. Since inherent vulnerability of coronary circulation of microminipigs has not been characterized, we performed dipyridamole-stress test to both ...
Kentaro Ando   +12 more
doaj   +1 more source

Nucleoside Transport Inhibition by Dipyridamole Prevents Angiogenesis Impairment by Homocysteine and Adenosine

open access: yesJournal of Pharmacy & Pharmaceutical Sciences, 2015
Purpose: Adenosine plays an important role in the pathogenesis of homocysteine-associated vascular complications. Methods: This study examined the effects of dipyridamole, an inhibitor for nucleoside transport, on impaired angiogenic processes caused by ...
Antony Kam   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy